Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria

Nitisinone, although unapproved for use in alkaptonuria (AKU), is currently the only homogentisic acid lowering therapy with a potential to modify disease progression in AKU. Therefore, safe use of nitisinone off-label requires identifying and managing tyrosine keratopathy. A 22-year-old male with A...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JIMD Rep
Main Authors: Khedr, M., Judd, S., Briggs, M. C., Hughes, A. T., Milan, A. M., Stewart, R. M. K., Lock, E. A., Gallagher, J. A., Ranganath, L. R.
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122026/
https://ncbi.nlm.nih.gov/pubmed/28942493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2017_62
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki